Thread by @aditya942000

Adi-Finechem #FAIRCHEM

-Adi Finechem Ltd. Founded in 1985 by Shri R.Harivallabhdas and Shri Nahoosh J Jariwala.

-It is engaged in mfg of Oleochemicals & Neutraceuticals.

-They operate through only one plant in SANAND,AHMEDAAHMEDABAD,GUJARAT.

- With the capacity of 72K MT inc. from 45K MT up 60% from 2016.

-The plant has one of the largest processing capacities for natural soft oil-based fatty acids in India.

-Their main products are
i) OLEOCHEMS-dimer, monomer, linoleic acid etc.

ii)Neutraceuticals - (Natural) Mixed Tocopherol and Sterol Concentrate

They r further undergoing expansion:
-Neutraceuticals - to manufacture sterols and higher concentration tocopherols.
-to manufacture bio-diesel using three by-products of its manufacturing process:

palmitic acid, monomer acid and residue.

-They hv developed and mastered the process of manufacturing its entire product range from waste/by product streams of natural vegetable oils.

Their buss segments can be divided into oleochems & Neutraceuticals

i)Oleochemicals (80% rev. contribution FY17) - Oleo Chemicals are chemicals derived from Plant and Animal Fats.
-They mfg a of range of oleo chemicals (high grade fatty acids) like dimer, monomer, linoleic acid.

-Pharmaceutical & personal care is the largest consumer of oleo.

The global oleo chemicals market is expected to reach $30.15 bn by 2024 & majority of demand is expected to come from ASIA PACIFIC REGION.
-Dimer acid is a major product,contributing 38% of overall revenue in FY19.
-Dimer Acid is used for making two kinds of polyamides:

i.e.Non-reactive and reactive.

-They r India's largest manufacturer of Dimer acid used in many consumer products including paints and enjoys a market share of ~70%.
Their Oleochems r mainly used in production of soaps, detergents, personal care products and paints.

CUSTOMERS - Asian Paints, Micro Inks, Arkema, etc.

Major Raw Materials – Acid oil a waste prod. Generated from processing of Oils like Soya,Sunflower,Corn,Cotton.

-Their vol. hv been increasing constantly since FY13.

ii) Neutraceuticals (36% of revenue in FY17) –a portmanteau of the words “nutrition” and “pharmaceutical”.

Major products - (Natural) Mixed Tocopherol Concentrate /Natural vitamin E which it supplies in the Nutraceutical and Health Care Industries.

CUSTOMERS r MNCs- BASF, Archer Daniels Midland, Cargill etc.
Raw material - Deodorizer Distillate a waste prod. Generated from processing of Oils like Soya,Sunflower,Corn,Cotton etc.

-Majority of sales from this segment is from exports.

-Since 2014 Neutraceuticals division has been on a downhill after realizations peaked out, although volumes r still increasing.
-on the basis of recent financial performance it seems prices have stabilized now.

-they are also working on an improved version of the product, as well as isolating and marketing other nutraceutical products.

FINANCIAL
Now coming to d financials it is more profitable business when compared to AROMA chem.
- Even the return ratios are quite healthy.

-Revenues hv been growing at CAGR OF 18% &Co. has never seen any decline in revenues over 10 yrs.

-PAT has grown @ 22% CAGR

-Even In FY15 after it ASP declined the revs. remained flat.

-they hv been constantly expanding recently they inc. their capacity to 72K MT in FY18.

-EBITDA & PAT MARGINS seems to be bottomed out in FY17 n moving up consistently after that.

DEBT: Long term:16crs
Short Term:44crs
Interest cost seems to be on a lil higher side at 10.9% for Fy20.
Though it is only 2% of d overall revenue.

Return Ratios r aslo healthy.
BOTH ROCE & ROE above 20 for most of the years.

-Their avg asset turn is 3-3.5x, even mentioned by mgt in AGM.
So,with NFA OF 126crs they can easily do turnover of 400crs+

OP.CASH FLOWS FOR LAST 10YRS - 164Crs
N.p for last 10 yrs - 150crs.
FCF hv been low but they hv been on expansion most of the time.

Risk:
-This business unlike that of aroma chemicals faces challenge from Chinese imports.
Infact in 2019 they faced shortage for its key raw materials, due to inc. demand from China, where customers r able to pay higher prices bcoz their products hv better margins.

-They hv also started to see increased competition from a new player entering domestic market.
-Impact of COVID on realizations.

MITIGATION OF RAW MAT. RISK -
In order to mitigate raw material risk they are now working on 3 potential substitute of their existing raw material

of which one is currently being used in production & other two r in laboratory testing.

Could not collect latest data for FY20 as co. doesnt conduct concalls nor even presentations.

Hope they wil communicate effectively after demeger.

Disclosure - Invested

@threadreaderapp unroll